ResMed Inc

ResMed Inc. develops and sells medical devices, masks, accessories, and cloud-based software used to diagnose, treat, and manage respiratory disorders. Its business spans sleep apnea and other breathing conditions, with operations and customers across the United States, Canada, Latin America, Europe, Asia, and other international markets.

36,9 %

61,1 %

26,9 %

+9,9 %

3.10

2.42

— ResMed Inc
%
Sleep and Breathing Health Devices88% Devices used to diagnose and treat sleep-disordered breathing and other respiratory conditions.
Masks and Other Consumables24% Mask systems, headgear, and related accessories used with therapy devices.
Residential Care Software12% Software-as-a-service tools for out-of-hospital care providers and care coordination.

ResMed sells to healthcare providers, durable medical equipment channels, homecare providers, and other organizations...

  • Sleep and breathing disorder providersprimary

    Clinics, physicians, and care channels that buy devices and masks for sleep apnea and respiratory therapy.

  • Homecare and durable medical equipment channelsprimary

    Providers that distribute therapy devices and consumables to patients for home use.

  • Hospitals and acute care settingssecondary

    Facilities that use ventilation devices, masks, and related respiratory products.

  • Out-of-hospital care providerssecondary

    Senior living, long-term care, home health, and hospice operators using SaaS workflow tools.

ResMed reports revenue across two broad regions: U.S., Canada and Latin America, and Combined Europe, Asia and other...

  • U.S., Canada and Latin America generated $835.0 million in the quarter
  • Combined Europe, Asia and other markets generated $420.9 million in the quarter
  • Global distribution supports device and mask replacement demand
  • International currency movements can affect reported software revenue
  • Regional care models influence adoption of home-based therapy

ResMed’s strategy centers on expanding connected care across sleep and respiratory disease through devices, masks, and...

01
Advance connected respiratory caremedium-term

Integrated devices and software improve patient outcomes and provider workflow.

02
Expand residential care softwaremedium-term

Software adds recurring revenue and deepens relationships with care providers.

03
Broaden global respiratory franchiselong-term

International reach diversifies demand and supports scale in devices and consumables.

ResMed is exposed to demand shifts in sleep apnea and respiratory care, where adoption depends on diagnosis rates,...

high

Foreign exchange volatility

International sales and software revenue are translated into U.S. dollars.

Scope
Global operations and non-U.S. revenue
Materiality
high
high

Supply chain disruption

Device and mask production depends on components, logistics, and manufacturing continuity.

Scope
Devices, masks, and accessories
Materiality
high
high

Regulatory and product liability exposure

Medical devices and software are subject to healthcare regulation and claims risk.

Scope
Sleep and breathing health products
Materiality
high
high

Cybersecurity and data privacy

Cloud-based monitoring and care software handle sensitive patient and provider data.

Scope
Residential Care Software and connected care platforms
Materiality
high
medium

Inflation in input and freight costs

Higher costs can pressure pricing and operating efficiency if not offset.

Scope
Manufacturing and distribution
Materiality
medium
Revenue recognition
Affects quarterly comparability and mix between product and software revenue
Warranty obligations
Impacts cost of sales and accrued liabilities
Goodwill and intangible assets
Can create non-cash charges if expected cash flows weaken
Foreign currency hedging
Can affect other income/expense and balance sheet volatility
Contingencies and legal proceedings
May affect expenses and liabilities if outcomes change

: 11/08/2026